Vision

Vision

Our vision is to defeat cancer. Our aim is to fully arm the patient’s immune system to successfully fight and thus win the battle against cancer. After passive checkpoint inhibition, we are now in the wake of a new era for cancer therapeutics, and OncoQR ML is first in line.

We are developing cancer immunotherapies that harness all four natural killing mechanisms of our immune system in a tumour specific way, which is required to defeat the cancers immune evading mechanisms.